AbbVie Inc. (ABBV): return on equity, 10 filed years
ROE at AbbVie Inc. was 128.7% in FY2024, the newest year it could be computed. Across the 7 computed years from FY2016 it ranged from 35.3% (FY2020) to 128.7% (FY2024), with a median of 74.9%.
Tonight's figure on the company page: n/a, recomputed 2026-10-15. The table is each filed year on its own terms, with the formula below; the current figure may use trailing twelve months or, where the explainer says so, a different denominator.
Year by year
| Fiscal year | ROE | Read from |
|---|---|---|
| FY2016 | 128.4% | 10-K, filed 2017-02-17 |
| FY2017 | 104.2% | 10-K, filed 2018-02-16 |
| FY2018 Filed shareholders equity is zero or below, so a return on it is not a measurement (n/m). | n/m | 10-K, filed 2019-02-27 |
| FY2019 Filed shareholders equity is zero or below, so a return on it is not a measurement (n/m). | n/m | 10-K, filed 2020-02-21 |
| FY2020 | 35.3% | 10-K, filed 2021-02-19 |
| FY2021 | 74.9% | 10-K, filed 2022-02-18 |
| FY2022 | 68.6% | 10-K, filed 2023-02-17 |
| FY2023 | 46.9% | 10-K, filed 2024-02-20 |
| FY2024 | 128.7% | 10-K, filed 2025-02-14 |
| FY2025 Filed shareholders equity is zero or below, so a return on it is not a measurement (n/m). | n/m | 10-K, filed 2026-02-20 |
How each year is computed
Net income / shareholders equity x 100
Each year is a ratio of lines in that year's filed annual report, with the nightly recompute's own rules for what counts as a filed line. Nothing is estimated, smoothed or filled in: a year that cannot be computed says why.
Read further
A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.